about
Organic compound characterization and source apportionment of indoor and outdoor quasi-ultrafine particulate matter in retirement homes of the Los Angeles BasinSecondary organic aerosol origin in an urban environment: influence of biogenic and fuel combustion precursors.A new look at inhalable metalliferous airborne particles on rail subway platforms.Bioaerosols in the Barcelona subway system.Formation and alteration of airborne particles in the subway environment.2001-2012 trends on air quality in Spain.PM₁₀ concentration in urban atmosphere around the eastern Tien Shan, Central Asia during 2007-2013.PM10 speciation and determination of air quality target levels. A case study in a highly industrialized area of Spain.Within-city contrasts in PM composition and sources and their relationship with nitrogen oxides.Particulate air pollution and preeclampsia: a source-based analysis.Factors controlling air quality in different European subway systems.Urban case studies: general discussion.Exposure to airborne particulate matter in the subway system.Application of optimally scaled target factor analysis for assessing source contribution of ambient PM10.Lanthanoid geochemistry of urban atmospheric particulate matter.Impact of fugitive emissions in ambient PM levels and composition: a case study in Southeast Spain.The effect of ventilation protocols on airborne particulate matter in subway systems.Spatial variability of trace elements and sources for improved exposure assessment in BarcelonaAIRUSE-LIFE+: a harmonized PM speciation and source apportionment in five southern European citiesOrganic aerosol source apportionment by offline-AMS over a full year in MarseilleOrigin of inorganic and organic components of PM 2.5 in subway stations of Barcelona, SpainOrganic compounds in aerosols from selected European sites – Biogenic versus anthropogenic sourcesEffects of two different biogenic emission models on modelled ozone and aerosol concentrations in EuropeDeposition of aerosol particles from a subway microenvironment in the human respiratory tract
P50
Q28679522-92B59E3A-01A0-46D9-B8EE-5B43CB3167F1Q31085828-98E42B80-BEBE-4F7B-A6E3-C6FB08B7BC9BQ35475345-64D693D9-BAAC-448B-AEBF-3A4139CB72C6Q36149298-656A21DF-6D89-41F0-BC2D-F6CB6579AA97Q36230601-96597D06-590F-4802-B760-26D221D3806CQ38420308-194763D3-DEB6-4822-BE9B-07FCB80AD9C6Q39129673-59EE82C6-4609-4C6A-8D4A-D146600B85A7Q39777088-3641D6EE-90BE-48B7-99D7-495A7313AE31Q40059696-78C2B040-6BBF-4078-A167-58E7998B7062Q40180980-C0D46C48-4779-463A-A9AD-211DF7775D5CQ40340967-3749BCE9-C800-4B0D-BDB4-D00603579654Q40386936-F058222C-F02C-46F7-B69B-00529068FE41Q41535121-398C84DB-9C8B-4410-B3D2-D2E4E72BC3CBQ44640855-4CC6012C-6BE3-4379-917A-1D0ACCE7AA32Q46360609-7E02216C-A12C-4DA7-96BE-CE43796D99F4Q46525181-BF5CABEE-B2D6-46A3-B012-FF95298F83EFQ50898268-D1F41809-EE17-4EB2-9E4D-F5FE4A40E925Q57015739-96A08DF1-1209-4BD5-9305-23CED82D434BQ57775765-1A667B97-7022-418A-9926-181736470CEAQ57882422-23F34719-D2F0-41CE-A089-0D131A4F6603Q58218505-1F4A6178-54FA-45E6-AF36-F2B099F1857DQ58330279-F424F883-7683-4EA3-B0D0-299F9778CBE2Q59303974-297B09CD-4799-4F29-B34A-486E4CB9100DQ59362672-3F1C306F-1C58-47E8-8A44-186CA018AADB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
María Cruz Minguillón
@ast
María Cruz Minguillón
@en
María Cruz Minguillón
@es
María Cruz Minguillón
@nl
María Cruz Minguillón
@sl
type
label
María Cruz Minguillón
@ast
María Cruz Minguillón
@en
María Cruz Minguillón
@es
María Cruz Minguillón
@nl
María Cruz Minguillón
@sl
prefLabel
María Cruz Minguillón
@ast
María Cruz Minguillón
@en
María Cruz Minguillón
@es
María Cruz Minguillón
@nl
María Cruz Minguillón
@sl
P106
P1153
15751232800
P21
P31
P496
0000-0002-5464-0391